crysvita solution
kyowa kirin, inc. - burosumab - solution - 10mg - burosumab 10mg - electrolytic, caloric and water balance agents, miscellanous
crysvita solution
kyowa kirin, inc. - burosumab - solution - 20mg - burosumab 20mg - electrolytic, caloric and water balance agents, miscellanous
crysvita solution
kyowa kirin, inc. - burosumab - solution - 30mg - burosumab 30mg - electrolytic, caloric and water balance agents, miscellanous
crysvita 10 mg solution for injection
kyowa kirin malaysia sdn. bhd. - burosumab -
crysvita 20 mg solution for injection
kyowa kirin malaysia sdn. bhd. - burosumab -
crysvita 30 mg solution for injection
kyowa kirin malaysia sdn. bhd. - burosumab -
crysvita
kyowa kirin holdings b.v. - burosumab - hypophosphatemia, familial; hypophosphatemic rickets, x-linked dominant; osteomalacia - drugs for treatment of bone diseases - crysvita is indicated for the treatment of x-linked hypophosphataemia, in children and adolescents aged 1 to 17 years with radiographic evidence of bone disease, and in adults.crysvita is indicated for the treatment of fgf23-related hypophosphataemia in tumour-induced osteomalacia associated with phosphaturic mesenchymal tumours that cannot be curatively resected or localised in children and adolescents aged 1 to 17 years and in adults.
crysvita 10mg1ml solution for injection vials
kyowa kirin ltd - burosumab - solution for injection - 10mg/1ml
crysvita 20mg1ml solution for injection vials
kyowa kirin ltd - burosumab - solution for injection - 20mg/1ml
crysvita 30mg1ml solution for injection vials
kyowa kirin ltd - burosumab - solution for injection - 30mg/1ml